IM Cannabis (IMCC) Divestments (2020 - 2026)

IM Cannabis' (IMCC) quarterly Divestments came in at $312.83 in Q1 2026, down 99.99% quarter-over-quarter from $3.8 million in Q2 2021.

IM Cannabis (IMCC) Divestments (2020 - 2026) Analysis & Trends

IM Cannabis' Divestments history runs 3 years deep, the most recent figure standing at $312.83 for Q1 2026.

On a quarterly basis, Divestments changed N/A year-over-year to $312.83 in Q1 2026; TTM through Mar 2026 was $3.8 million, a N/A change from a year earlier, with the FY2024 full-year figure at -$252718.2, changed N/A from the prior year.
Divestments declined to $312.83 in Q1 2026 per IMCC's latest filing, from $3.8 million in the prior quarter.
Across five years, Divestments topped out at $312.83 in Q1 2026 and bottomed at $312.83 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	42.00 Mn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	3.28 Mn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	63.20 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	IM Cannabis	591,792.44	-193,562.09	1.03 Mn	312.83

Download Data